| Assignment | Project | Issuer | Period | Status |
|---|---|---|---|---|
| Broad-spectrum Oral COVID-19 Treatment: IND Approval for DieckolEntry into Phase 1 Clinical Trials | Infectious Disease PreventionTreatment Technology Development | MOHW KHIDI |
Jul. 2024-Dec. 2026 | Ongoing |
| AntiviralAnti-cancer Therapy Development Using LncRNA Regulation Technology: Mechanism ResearchClinical Application for New Drug Development Targeting hepatitis C virus (HCV)Hepatocellular Carcinoma (HCC) | Deep Tech TIPS | MSS TIPA |
Jul. 2024-Jun. 2027 | Ongoing |
| mRNA Therapeutic Platform Development for Treating Viral Acute Respiratory DiseasesCreation of an Evaluation System | Infectious Disease PreventionTreatment Technology Development | MOHW KHIDI |
Jul. 2022-Dec. 2024 | Completed |
| Research into the Potential of Non-Coding RNA Platforms to Prevent HCV-Induced Hepatocellular Carcinoma (HCC) | National Crisis Overcoming Viral Infection Technology Development | MOHW KDCA NIH |
May. 2022-Dec. 2024 | Completed |